Blaine Templeman is CLO at ADURO BIOTECH, INC. (ADRO). They have made 8 open-market trades across 1 company since 2017, most recently 2020-09-15.
CIK 0001653641
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ADRO | 121,916 | $1.8M |
Shares reported on the most recent Form 4, priced at the 2020-09-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ADRO | SELL | 2020-09-15 | 2020-09-17 | $2.39 | $30K | -9.1% | N/A | N/A |
| ADRO | SELL | 2020-08-07 | 2020-08-11 | $2.55 | $20K | +20.6% | -6.5% | N/A |
| ADRO | SELL | 2019-12-12 | 2019-12-16 | $1.16 | $1K | +6.3% | +10.7% | +104.5% |
| ADRO | SELL | 2019-09-13 | 2019-09-17 | $1.31 | $17K | -21.1% | -18.8% | -16.5% |
| ADRO | SELL | 2018-12-12 | 2018-12-14 | $2.93 | $4K | -5.2% | +4.4% | +47.2% |
| ADRO | SELL · 10b5-1 | 2018-11-20 | 2018-11-20 | $2.91 | $2K | -18.0% | -7.2% | +27.2% |
| ADRO | SELL | 2018-09-24 | 2018-09-25 | $5.81 | $119K | +0.0% | -30.4% | -58.0% |
| ADRO | SELL | 2018-09-13 | 2018-09-14 | $6.50 | $39K | -11.8% | -6.0% | -59.9% |
| ADRO | SELL · 10b5-1 | 2018-05-17 | 2018-05-21 | $8.15 | $16K | +8.3% | +2.6% | -23.1% |
| ADRO | SELL · 10b5-1 | 2017-12-18 | 2017-12-20 | $8.25 | $24K | -8.1% | -9.3% | +14.3% |
| ADRO | SELL · 10b5-1 | 2017-11-17 | 2017-11-17 | $8.85 | $2K | +7.3% | -9.0% | -31.1% |
| ADRO | SELL · 10b5-1 | 2017-09-18 | 2017-09-20 | $11.20 | $32K | +0.5% | -16.0% | -25.6% |
| ADRO | SELL | 2017-09-13 | 2017-09-14 | $10.99 | $39K | -5.0% | -14.4% | -25.2% |
| ADRO | SELL · 10b5-1 | 2017-05-17 | 2017-05-18 | $9.65 | $16K | +1.0% | +6.1% | +14.1% |
| ADRO | SELL · 10b5-1 | 2017-01-11 | 2017-01-13 | $11.95 | $45K | -8.3% | -10.8% | -22.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.